Sorrento Therapeutics, Inc.
LSE: 0L85.L0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- London Stock Exchange
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- CEO
- Henry H. Ji
- Employees
- 949
- Headquarters
- San Diego, United States
- IPO year
- 2018
- Market cap
- $1.4M
- Website
- https://www.sorrentotherapeutics.com
Loading 0L85…
Loading profile data…Frequently asked questions about 0L85
What does Sorrento Therapeutics, Inc. (0L85.L) do?
Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
Where does 0L85.L trade?
Sorrento Therapeutics, Inc. (0L85.L) trades on the London Stock Exchange.
What sector is 0L85.L in?
Sorrento Therapeutics, Inc. (0L85.L) operates in the Healthcare sector, specifically in the Medical - Pharmaceuticals industry.
Who is the CEO of Sorrento Therapeutics, Inc.?
Henry H. Ji is the chief executive officer of Sorrento Therapeutics, Inc. (0L85.L).
Where is Sorrento Therapeutics, Inc. headquartered?
Sorrento Therapeutics, Inc. is headquartered in United States.
Does 0L85.L pay a dividend?
Sorrento Therapeutics, Inc. (0L85.L) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did 0L85.L go public?
Sorrento Therapeutics, Inc. (0L85.L) completed its initial public offering in 2018.